Quarterly report pursuant to Section 13 or 15(d)

Stockholders' (Deficit) Equity - Addtional Information (Details)

v3.23.3
Stockholders' (Deficit) Equity - Addtional Information (Details)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 18, 2023
USD ($)
Jul. 19, 2023
USD ($)
Jul. 18, 2023
Jun. 29, 2023
Apr. 19, 2023
USD ($)
$ / shares
shares
Sep. 30, 2022
shares
Sep. 30, 2023
USD ($)
shares
Sep. 30, 2022
shares
Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]                  
Forward split ratio       0.25     0.25   0.25
Net proceeds from offering             $ 6,431,612    
Debt Seller | Maestro Health LLC                  
Subsidiary, Sale of Stock [Line Items]                  
Percentage of payment on net proceeds of offering until such time as purchase price paid in full         35.00%        
Payment on net proceeds of offering until such time as purchase price paid in full         $ 2,294,751        
Percentage of payment on net proceeds of offering due amount as purchase price to be paid     50.00%            
Payment on net proceeds of offering due amount as purchase price to be paid $ 947,376 $ 1,147,376              
Paid to seller $ 200,000                
Common Stock [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Number of shares issued | shares             1,850,000    
Shares issued to vendors in exchange for services (in shares) | shares           1,875 25,000 7,500  
Public Offering                  
Subsidiary, Sale of Stock [Line Items]                  
Number of shares issued | shares         1,850,000        
Price per share | $ / shares         $ 4        
Gross proceeds from offering         $ 7,400,000        
Net proceeds from offering         $ 6,400,000